Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
NIKKEI 225
38,274.05
-131.61
(-0.34%)
HANG SENG
17,763.03
+16.12
(+0.09%)
CRUDE OIL
79.13
-2.80
(-3.42%)
GOLD FUTURES
2,326.30
+23.40
(+1.02%)
DOW
37,901.62
+85.70
(+0.23%)
Bitcoin GBP
45,506.77
-1,810.10
(-3.83%)
Money
Family finances
Who is the breadwinner in your family and does it matter?
CHINA RESOURCES PHARMACEUTICAL (CRPGF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5600
0.0000
(0.00%)
At close: 10:23AM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
267,329,951
254,106,366
236,806,169
200,423,023
Cost of revenue
225,686,206
214,971,606
201,425,883
168,129,162
Gross profit
41,643,745
39,134,760
35,380,286
32,293,861
Operating expenses
Selling general and administrative
27,150,842
25,512,123
23,766,959
21,593,940
Total operating expenses
26,672,078
25,047,682
23,201,973
20,972,869
Operating income or loss
14,971,667
14,087,078
12,178,313
11,320,992
Interest expense
3,104,603
2,853,993
2,744,681
3,153,273
Income before tax
10,391,432
9,855,713
8,408,432
7,075,508
Income tax expense
2,023,316
2,012,402
1,761,026
1,751,867
Income from continuing operations
8,368,116
7,843,311
6,647,406
5,323,641
Net income
4,160,426
4,147,412
3,768,889
3,297,126
Net income available to common shareholders
4,160,426
4,147,412
3,768,889
3,297,126
Basic EPS
0.66
0.66
0.60
0.52
Diluted EPS
0.66
0.66
0.60
0.52
Basic average shares
6,282,510
6,282,510
6,282,510
6,283,123
Diluted average shares
6,282,510
6,282,510
6,282,510
6,283,123
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.